M&A | Shaping GCT Innovation - 2021 World Medical Innovation Forum
May 2–4, 2022

M&A | Shaping GCT Innovation

M&A | Shaping GCT Innovation

Wednesday, May 19, 2021

11:50 AM – 12:15 PM

The GCT M&A market is booming – many large pharmas have made at least one significant acquisition. How should we view the current GCT M&A market? What is its impact of the current M&A market on technology development? Are these M&A trends new are just another cycle? Has pharma strategy shifted and, if so, what does it mean for GCT companies? What does it mean for patients? What are the long-term prospects – can valuations hold up?

Adam Koppel, MD, PhD
  • Managing Director, Bain Capital Life Sciences
Debbie Baron
  • Senior Vice President, Worldwide Business Development, Pfizer
Kenneth Custer, PhD
  • Vice President, Business Development and Lilly New Ventures, Eli Lilly and Company
Marianne De Backer, PhD
  • Head of Strategy, Business Development & Licensing, and Member of the Executive Committee, Bayer
Sean Nolan
  • Board Chairman, Encoded Therapeutics & Affinia
  • Executive Chairman, Jaguar Gene Therapy & Istari Oncology
  • Q&A

    12:20 PM – 12:35 PM

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA